Influence of initial antigen-independent events on acute allograft rejection: inhibition by a soluble P-selectin ligand and low-dose cyclosporine in combination.
Kusaka
M
M
Harvard Medical School, Department of Surgery, Brigham and Women's Hospital, Boston, USA.
Nadeau
K C
KC
Takada
M
M
Nagano
H
H
Shaw
G D
GD
Tilney
N L
NL
D000208:Acute Disease; D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008562:Membrane Glycoproteins / Q000627:therapeutic use*; D019007:P-Selectin / Q000502:physiology*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D008562:Membrane Glycoproteins; D019007:P-Selectin; C084882:P-selectin ligand protein; D016572:Cyclosporine